Sectors
YDES
YD Bio Limited Ordinary Shares
2.59
1 x 2.42
2 x 2.68
bid
ask
+
0.08
3.14%
10:56 AM
timesize
| Ytd | -78.76% | |
| 1y | -80.62% |
2.42
day range
2.76
1.70
52 week range
25.00
| Open | 2.76 | Prev Close | 2.51 | Low | 2.42 | High | 2.76 | Mkt Cap | 183.37M |
| Vol | 10.37K | Avg Vol | 134.30K | EPS | -0.12 | P/E | -21.57 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | 0.77 | Inst. Own | 0.35% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.48 | 200-d Avg | 7.35 | 1yr Est | 0.00 |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2025-09-29 | Cerity Partners LLC | 32.41K | 429.06K | 0.05% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2025-09-29 | Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF | 20.86K | 276.21K | 0.03% |